Hyaluronidase as a Successful Treatment Modality for Scleroderma-Induced Microstomia

Dermatol Surg. 2022 Sep 1;48(9):1014-1015. doi: 10.1097/DSS.0000000000003543. Epub 2022 Jul 13.
No abstract available

MeSH terms

  • Humans
  • Hyaluronoglucosaminidase / therapeutic use
  • Microstomia*
  • Scleroderma, Localized* / complications
  • Scleroderma, Localized* / drug therapy
  • Scleroderma, Systemic* / complications

Substances

  • Hyaluronoglucosaminidase